NASDAQ · DMIIU
Financial Services · Asset Management
$10.23
Up+$0.07 (+0.68%)
Updated Nov 6, 2026, 12:27 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · DMIIU
1M range · 4 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
DMIIU closed at $10.23 after 4 trading sessions, up 0.30% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $10.23 | $10.265 | $10.23 | $10.2307 | 4.17K |
| Oct 12, 2026 | $10.21 | $10.25 | $10.21 | $10.25 | 3.79K |
| Oct 9, 2026 | $10.225 | $10.25 | $10.225 | $10.23 | 1.26K |
| Oct 8, 2026 | $10.20 | $10.20 | $10.20 | $10.20 | 100 |
The latest Smart Investors Daily articles mentioning DMIIU.
Company
Market Activity
Research & News
DMIIU research
Company profile and research snapshot.
Drugs Made In America Acquisition II Corp is a blank check Company.
Consensus and target data currently published for this company.
No generated briefing is available yet.
seekingalpha.com · Sep 27, 2025
One IPO and four SPACS debuted this week. Six IPOs and three SPACs submitted initial filings. Two sizable deals are currently scheduled to price in the week ahead as the 3Q IPO market comes to a close.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning DMIIU.
No results
No recent SID articles mention DMIIU.
